期刊
JOURNAL OF NEUROIMMUNOLOGY
卷 214, 期 1-2, 页码 93-100出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/j.jneuroim.2009.07.006
关键词
CIDP; Guillain-Barre syndrome; S1P receptors; NOD mice; FTY720; SEW2871
资金
- National Institute of Health Grant [R21 NS049014]
- Miller Group Charitable Trust Fund
- Jack Miller Center for Peripheral Neuropathy
- Novartis (Basel, Switzerland) [FTY720]
We investigated potential therapeutic effects of sphingosine-1-phosphate (S1P) receptor modulators FTY720 (fingolimod) and selective S1P1 agonist SEW2871 on a spontaneous autoimmune polyneuropathy (SAP) when given orally at 7 mo (anticipated disease onset) for 4 weeks. Clinical severity, electrophysiologic and histological findings were ameliorated in mice treated with 1 mg/kg of FTY720. Subsequent studies showed that SEW2871 was also effective in halting the progression of SAP, which was accompanied by decreased proliferative and cytokine responses to myelin protein zero (P0), and an increase in regulatory T cells. We conclude that SIP receptor modulators may play a therapeutic role in autoimmune neuropathies. (c) 2009 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据